PTC Therapeutics, Inc. Basic Shares Outstanding (Weighted Average)
PTC Therapeutics, Inc. (PTCT) reported Basic Shares Outstanding (Weighted Average) of 83.01 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-07-30
- PTC Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 83.01M shares, a 6.21% increase year-over-year.
- PTC Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 82.52M shares, a 5.64% increase year-over-year.
- PTC Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 82.21M shares, a 6.45% increase year-over-year.
- PTC Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 78.47M shares, a 2.01% increase year-over-year.
- PTC Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 79.53M shares, a 3.50% increase from fiscal 2024.
- PTC Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 76.85M shares, a 2.68% increase from fiscal 2023.
- PTC Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 74.84M shares, a 4.34% increase from fiscal 2022.
- PTC Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 71.73M shares, a 1.79% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | 83.01M shares 10-Q · filed 2026-07-30 | 82.77M shares 10-Q · filed 2026-07-30 | 82.58M shares derived: average of 3 quarters · filed 2026-07-30 | 81.55M shares derived: average of 4 quarters · filed 2026-07-30 | |
| 2026-03-31 | 82.52M shares 10-Q · filed 2026-05-07 | 82.37M shares derived: average of 2 quarters · filed 2026-05-07 | 81.07M shares derived: average of 3 quarters · filed 2026-05-07 | 80.34M shares derived: average of 4 quarters · filed 2026-07-30 | |
| 2025-12-31 | 82.21M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | 80.34M shares derived: average of 2 quarters · filed 2026-02-19 | 79.61M shares derived: average of 3 quarters · filed 2026-07-30 | 79.53M shares 10-K · filed 2026-02-19 | |
| 2025-09-30 | 78.47M shares 10-Q · filed 2025-11-04 | 78.31M shares derived: average of 2 quarters · filed 2026-07-30 | 78.64M shares 10-Q · filed 2025-11-04 | 77.99M shares derived: average of 4 quarters · filed 2026-07-30 | |
| 2025-06-30 | 78.15M shares 10-Q · filed 2026-07-30 | 78.44M shares 10-Q · filed 2026-07-30 | 77.83M shares derived: average of 3 quarters · filed 2026-07-30 | 77.61M shares derived: average of 4 quarters · filed 2026-07-30 | |
| 2025-03-31 | 78.12M shares 10-Q · filed 2026-05-07 | 77.67M shares derived: average of 2 quarters · filed 2026-05-07 | 77.42M shares derived: average of 3 quarters · filed 2026-05-07 | 77.25M shares derived: average of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | 77.23M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | 77.08M shares derived: average of 2 quarters · filed 2026-02-19 | 76.96M shares derived: average of 3 quarters · filed 2026-02-19 | 76.85M shares 10-K · filed 2026-02-19 | |
| 2024-09-30 | 76.93M shares 10-Q · filed 2025-11-04 | 76.83M shares derived: average of 2 quarters · filed 2025-11-04 | 76.72M shares 10-Q · filed 2025-11-04 | 76.41M shares derived: average of 4 quarters · filed 2026-02-19 | |
| 2024-06-30 | 76.73M shares 10-Q · filed 2025-08-07 | 76.61M shares 10-Q · filed 2025-08-07 | 76.24M shares derived: average of 3 quarters · filed 2026-02-19 | 76.02M shares derived: average of 4 quarters · filed 2026-02-19 | |
| 2024-03-31 | 76.50M shares 10-Q · filed 2025-05-06 | 76.00M shares derived: average of 2 quarters · filed 2026-02-19 | 75.79M shares derived: average of 3 quarters · filed 2026-02-19 | 75.53M shares derived: average of 4 quarters · filed 2026-02-19 | |
| 2023-12-31 | 75.50M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | 75.44M shares derived: average of 2 quarters · filed 2026-02-19 | 75.20M shares derived: average of 3 quarters · filed 2026-02-19 | 74.84M shares 10-K · filed 2026-02-19 | 74.84M shares 10-K · filed 2024-02-29 |
| 2023-09-30 | 75.38M shares 10-Q · filed 2024-11-07 | 75.05M shares derived: average of 2 quarters · filed 2024-11-07 | 74.62M shares 10-Q · filed 2024-11-07 | 74.13M shares derived: average of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | 74.73M shares 10-Q · filed 2024-08-08 | 74.23M shares 10-Q · filed 2024-08-08 | 73.71M shares derived: average of 3 quarters · filed 2025-02-27 | 73.20M shares derived: average of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | 73.73M shares 10-Q · filed 2024-04-25 | 73.20M shares derived: average of 2 quarters · filed 2025-02-27 | 72.68M shares derived: average of 3 quarters · filed 2025-02-27 | 72.36M shares derived: average of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | 72.67M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 72.16M shares derived: average of 2 quarters · filed 2025-02-27 | 71.90M shares derived: average of 3 quarters · filed 2025-02-27 | 71.73M shares 10-K · filed 2025-02-27 | |
| 2022-09-30 | 71.65M shares 10-Q · filed 2023-10-26 | 71.51M shares derived: average of 2 quarters · filed 2023-10-26 | 71.42M shares 10-Q · filed 2023-10-26 | 71.23M shares derived: average of 4 quarters · filed 2024-02-29 | |
| 2022-06-30 | 71.37M shares 10-Q · filed 2023-08-03 | 71.29M shares 10-Q · filed 2023-08-03 | 71.09M shares derived: average of 3 quarters · filed 2024-02-29 | 70.96M shares derived: average of 4 quarters · filed 2024-02-29 | |
| 2022-03-31 | 71.22M shares 10-Q · filed 2023-04-27 | 70.94M shares derived: average of 2 quarters · filed 2024-02-29 | 70.82M shares derived: average of 3 quarters · filed 2024-02-29 | 70.72M shares derived: average of 4 quarters · filed 2024-02-29 | |
| 2021-12-31 | 70.67M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | 70.63M shares derived: average of 2 quarters · filed 2024-02-29 | 70.56M shares derived: average of 3 quarters · filed 2024-02-29 | 70.47M shares 10-K · filed 2024-02-29 | |
| 2021-09-30 | 70.59M shares 10-Q · filed 2022-10-27 | 70.50M shares derived: average of 2 quarters · filed 2022-10-27 | 70.40M shares 10-Q · filed 2022-10-27 | ||
| 2021-06-30 | 70.41M shares 10-Q · filed 2022-08-04 | 70.30M shares 10-Q · filed 2022-08-04 | |||
| 2021-03-31 | 70.19M shares 10-Q · filed 2022-05-03 | ||||
| 2020-12-31 | 66.03M shares 10-K · filed 2023-02-21 | ||||
| 2019-12-31 | 58.86M shares 10-K · filed 2022-02-22 | ||||
| 2014-12-31 | 31.57M shares 10-K · filed 2015-03-02 | ||||
| 2013-12-31 | 24.33M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | 24.07M shares derived: average of 2 quarters · filed 2015-03-02 | 16.93M shares derived: average of 3 quarters · filed 2015-03-02 | 12.83M shares 10-K · filed 2015-03-02 | |
| 2013-09-30 | 23.80M shares 10-Q · filed 2013-11-14 | 13.23M shares derived: average of 2 quarters · filed 2013-11-14 | 9.00M shares 10-Q · filed 2013-11-14 | ||
| 2013-06-30 | 2.65M shares 10-Q · filed 2013-08-13 | 1.33M shares 10-Q · filed 2013-08-13 | |||
| 2012-12-31 | 4.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | 4.52K shares derived: average of 2 quarters · filed 2015-03-02 | 4.05K shares derived: average of 3 quarters · filed 2015-03-02 | 3.33K shares 10-K · filed 2015-03-02 | |
| 2012-09-30 | 4.54K shares 10-Q · filed 2013-11-14 | 3.82K shares derived: average of 2 quarters · filed 2013-11-14 | 2.94K shares 10-Q · filed 2013-11-14 | ||
| 2012-06-30 | 3.09K shares 10-Q · filed 2013-08-13 | 2.10K shares 10-Q · filed 2013-08-13 | |||
| 2011-12-31 | 1.09K shares 10-K · filed 2014-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |